Compound ID | 413
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Use against CAP |
Description: | Oral |
Institute where first reported: | LG Life Sciences, South Korea |
Year first mentioned: | 1999 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9851428 |
Citation: | https://journals.asm.org/doi/10.1128/aac.44.12.3272-3277.2000 |